Post by
Adventurous on Jan 25, 2022 10:33am
Share Price is Not A Reflection of Nextleaf's Health
For any company, share price is rarely a reflexion of its current health. Rather a balance between positive and negative opinions at best, in most cases a reflection of the broad opinion about a sector or the general market - as it is today.
What we need from coming Nextleaf Q reports are signs that revenues from sales were higher than costs of sales for the month of September alone. Confirmation in the Annual Report that Nextleaf made money on sales over the months of Oct, Nov and Dec will be great. That does not mean the company turned a profit, yet, because of its other general costs - but that with the coming increase of sales in 2022 this will very likely be the case.
The fact Nextleaf is making money on sales will be a clear indicator of the company's health, whatever the share price does on low volume like today.
Comment by
shneps on Jan 25, 2022 10:47am
I agree with you Adventurous. The one key point is that sales in BC will only be for the month of September. Plus the other revenue streams that currently are "bumpy" at best. Looking for signs but not significant gross revenues yet.
Comment by
stealthct on Jan 25, 2022 5:03pm
Bumpy? It's lumpy. Lol January ending... New sales or what?
Comment by
swyint123888 on Jan 26, 2022 2:42am
We all know the end of February is what we are waiting for......so I'll be looking at "subsequent events" in the January report to see if a tidbit is in there.....none the less January report will be the best revs ever for the company and clearly things are only getting better in that regard.....even a novice can see this thus the increased volume and nibbling that is going on